Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma (1286)

In: Gynecologic Oncology · 2023 · vol. 176 , pp. S178–S179 · doi:10.1016/j.ygyno.2023.06.192 · W4386948306
article OA: bronze CC0
AI-generated summary by claude@2026-06, 2026-06-10

Researchers investigated spontaneous antibody responses in ovarian carcinoma and found that these responses can antagonize malignant progression of the disease.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK